Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply. uri icon

Overview

publication date

  • May 16, 2023

Research

keywords

  • Antiviral Agents
  • COVID-19
  • COVID-19 Drug Treatment
  • Fluvoxamine

Identity

Digital Object Identifier (DOI)

  • 10.1001/jama.2023.5064

PubMed ID

  • 37191706

Additional Document Info

volume

  • 329

issue

  • 19